Category: News - Page 2 - Psychedelic Alpha

Our 2022 Year in Review is now live.

Read more about the article MagicMed to Be Acquired by Nasdaq-Listed Company

MagicMed to Be Acquired by Nasdaq-Listed Company

Post published:May 24, 2021
Post category:Analysis News

Read more about the article MindMed Becomes Second Psychedelic Drug Development Company to List on the Nasdaq

MindMed Becomes Second Psychedelic Drug Development Company to List on the Nasdaq

Post published:April 27, 2021
Post category:News

Read more about the article Experiential Psilocybin-assisted Therapy Training Program, Approved by Health Canada, Gets Underway

Experiential Psilocybin-assisted Therapy Training Program, Approved by Health Canada, Gets Underway

Post published:March 2, 2021
Post category:Analysis News

Read more about the article UK Regulators Approve Beckley Psytech Study of Psilocybin for Debilitating Headache Condition

UK Regulators Approve Beckley Psytech Study of Psilocybin for Debilitating Headache Condition

Post published:January 27, 2021
Post category:Analysis News

Read more about the article North American Psychedelics Index Published: Which Companies Will Be in the First Psychedelic ETF?

North American Psychedelics Index Published: Which Companies Will Be in the First Psychedelic ETF?

Post published:January 21, 2021
Post category:Analysis News

Read more about the article First Psychedelic ETF Expected to Launch January 2021 (NEO:PSYK)

First Psychedelic ETF Expected to Launch January 2021 (NEO:PSYK)

Post published:December 28, 2020
Post category:Analysis News

Read more about the article Beckley Psytech Raises £14m ($18.6m) to Advance Development of 5-MeO-DMT for Neuropsychiatric Diseases

Beckley Psytech Raises £14m ($18.6m) to Advance Development of 5-MeO-DMT for Neuropsychiatric Diseases

Post published:December 19, 2020
Post category:News

Read more about the article Canada to Consider Allowing Psychedelic-Assisted Therapy under Special Access Program Amendment

Canada to Consider Allowing Psychedelic-Assisted Therapy under Special Access Program Amendment

Post published:December 12, 2020
Post category:Analysis News

Read more about the article UK Regulators Approve World’s First DMT for Depression Clinical Trial

UK Regulators Approve World’s First DMT for Depression Clinical Trial

Post published:December 10, 2020
Post category:News

Read more about the article Research Suggests Past Antidepressant Usage Reduces Efficacy of MDMA-Assisted Psychotherapy for PTSD

Research Suggests Past Antidepressant Usage Reduces Efficacy of MDMA-Assisted Psychotherapy for PTSD

Post published:November 23, 2020
Post category:News

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.